the staff of the Ridgewood blog
Branchburg NJ, Swiss pharmaceutical leader Roche has unveiled a massive $50 billion investment plan to expand its U.S. manufacturing and operations, with a portion of the expansion expected to take place in New Jersey. The strategic move comes as the pharmaceutical industry navigates the impact of President Donald Trump’s tariffs on imported medical products.